RAD Virtual Seminar - Sponsored by Lilly - December 2022

JOIN OUR VIRTUAL SEMINAR ON DEMAND:

Battle of the 2 Titans: When is a patient with atopic dermatitis
eligible for systemic treatment?


About the Meeting:

The goal of this program is to improve the recognition and the identification of patients that require long term control of their atopic dermatitis, with advanced systemic therapy. Upon completion of this activity, participants will:

• Understand utility and limitations of defining patients as mild, moderate or severe and using assessment tools in practice
• Improve identification of patients requiring systemic therapy
 

 

Speakers:

Jonathan I. Silverberg, MD, PhD, MPH
Associate Director, Department of Dermatology
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC, USA

 

Eric Simpson, MD, MPH
Professor of Dermatology, School of Medicine
Oregon Health & Science University
Portalnd, Oregon, USA

 

 

https://djbpnesxepydt.cloudfront.net/radv/logo_lilly_1624384342553.png

VV-Centralized Congress-US-DEL-0795
@Lilly USA, LLC 2022. All rights reserved